News & Events

Join StageBio at the 2022 ESTP Congress of Toxicologic Pathology

The StageBio team is looking forward to exhibiting and attending The 19th European Congress of Toxicologic Pathology (ESTP). Attendees will have access to new research, educational and professional development programming, and networking opportunities for anyone working in the area of the female reproductive system and in toxicologic pathology.

StageBio is hosting a booth and our team is looking forward to connecting with you in person!  We invite you to set up some time to connect with us at booth #10. Bring plenty of questions and our team will be ready to share! 

The ESTP discussion will be: "Think Female: Toxicologic Pathology of the Female Reproductive System". The congress will focus on the female reproductive system and will cover the normal and pathologic female reproductive system and new techniques, models and challenges in clinical development and risk assessment of hormonally active/endocrine-related compounds.

Make sure you are familiar with the Maastricht, The Netherlands health guidelines on staying safe and preventing the spread of COVID here. For more information on how ESTP plans to stay safe and adhere to safety protocols, click here.

See you at ESTP September 13-16, 2022!

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at

Back to Index

Learn more about StageBio’s COVID-19 response